NASDAQ:CAPR

Capricor Therapeutics Stock Predictions

etoro logo Buy CAPR
*Your capital is at risk
$27.64
+0.300 (+1.10%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CAPR Prediction Chart

CAPR Predictions History

Latest community submissions for CAPR.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 23, 2026 $29.97 +3.00% $30.10 V 99.58% 5
Mar 23, 2026 $29.65 +1.88% $30.10 V 98.49% 1
Mar 23, 2026 Bullish $30.10 X 1
Jan 27, 2026 $24.26 +2.72% $23.52 X 96.85% 0
Jan 27, 2026 $24.02 +1.70% $23.52 X 97.87% 0
Jan 27, 2026 $65.00 +175.19% Unrealistic Excluded from avg $23.52 X 0.00% 0
Sep 30, 2025 $7.20 -2.80% $7.21 V 99.90% 10
Sep 30, 2025 $7.28 -1.75% $7.21 V 99.02% 2
Sep 30, 2025 Bullish $7.21 X 0
May 30, 2025 $10.50 +4.08% $9.89 X 93.82% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CAPR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CAPRICOR THERAPEUTICS
Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE